Parathyroidectomy improves survival in patients with severe hyperparathyroidism: a comparative study

Area of Science:

• Nephrology
• Endocrinology
• Surgical Oncology

Background:

• Secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD) is linked to increased mortality.
• Definitive data on parathormone control reducing mortality is limited.
• This study investigates the impact of parathyroidectomy (PTX) on mortality in severe SHPT patients.

Purpose of the Study:

• To compare mortality rates between CKD patients with severe SHPT who underwent PTX and those who did not.
• To evaluate the effectiveness of PTX in reducing mortality in this patient cohort.

Main Methods:

• Retrospective study of 251 CKD patients with severe SHPT.
• Data collected from patients referred for PTX between 2005 and 2012.
• Comparison of mortality between patients with and without access to PTX.

Main Results:

• Only 49% of eligible patients had access to PTX.
• After a mean follow-up of 23 months, 72 patients died.
• PTX was associated with a significantly lower relative risk of death (0.428; p<0.0001).
• Mortality risk was independently associated with age, low 25 vitamin D, and lack of PTX access (OR 4.13).

Conclusions:

• Parathyroidectomy (PTX) demonstrates a significant benefit in reducing mortality for patients with severe SHPT.
• The high mortality observed underscores the urgent need for improved treatment strategies for these patients.
• Ensuring access to PTX is critical for improving survival outcomes in CKD patients with severe SHPT.